Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
20.46
-0.37 (-1.78%)
At close: Nov 5, 2026, 4:00 PM EST
20.12
-0.34 (-1.67%)
After-hours: Nov 5, 2026, 7:30 PM EST
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $691.50M in the quarter ending September 30, 2026, a decrease of -1.40%. This brings the company's total for the last twelve months to $2.67B, down -3.38% year-over-year. In the year 2025, Fortrea Holdings had annual revenue of $2.72B with 1.00% growth. That makes Fortrea Holdings the 4,136th largest company in the world by revenue and 1,125th in the United States.
Revenue (ttm)
$2.67B
Revenue Growth
-3.38%
P/S Ratio
0.74
Revenue / Employee
$190,479
Employees
14,000
Market Cap
1.97B
Revenue by Geography
- North America 1.29B 47.4%
- Europe 851.70M 31.3%
- Other Geographic 582.10M 21.4%
Fiscal year ended Dec 31, 2025 See the full Fortrea Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.72B | 27.00M | 1.00% |
| Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
| Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
| Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sarepta Therapeutics | 1.97B |
| Lakefront Biotherapeutics NV | 1.13B |
| Vir Biotechnology | 303.23M |
| Maravai LifeSciences Holdings | 208.78M |
| Mesoblast | 120.25M |
| Septerna | 98.88M |
| Precigen | 85.72M |
FTRE News
- 3 days ago - Fortrea price target raised to $26 from $23 at TD Cowen - TheFly
- 6 days ago - Fortrea price target raised to $28 from $25 at Evercore ISI - TheFly
- 6 days ago - Fortrea price target raised to $27 from $22 at Citi - TheFly
- 6 days ago - Fortrea price target raised to $26 from $24 at Baird - TheFly
- 7 days ago - Barclays ups Fortrea target, says buy the selloff - TheFly
- 7 days ago - Fortrea Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 7 days ago - Fortrea Holdings Earnings release: Q3 2026 - Filings
- 7 days ago - Fortrea Holdings Slides: Q3 2026 - Filings